PRODUCTION OF COMPLEMENT CLEAVAGE PRODUCT, C3A, BY ACTIVATED MACROPHAGES AND ITS TUMOROLYTIC EFFECTS
- 1 January 1978
- journal article
- research article
- Vol. 31 (3) , 512-517
Abstract
Mouse peritoneal macrophages were activated in serum-free culture with [Escherichia coli] lipopolysaccharide, dextran sulfate or C3b [b fragment of complement component 3]. They liberated into the culture medium a cytolytic factor and a factor which was pharmacologically indistinguishable from C3a. The cytolytic activity was neutralized by antiserum against C3a. Macrophages can apparently be activated by C3b (or agents that generate C3b) to cleave C3, which they themselves produce. In this way the activated macrophages form C3a, which appears to be a major factor in macrophage-mediated cytolysis. These findings have implications in tumor immunity and in the pathogenesis of inflammatory reactions.This publication has 17 references indexed in Scilit:
- In vitro synthesis of factor B of the alternative pathway of complement activation by mouse peritoneal macrophagesEuropean Journal of Immunology, 1976
- EFFECTS OF ACTIVATED COMPLEMENT COMPONENTS ON ENZYME-SECRETION BY MACROPHAGES1976
- Interaction of C3b, B, and D in the alternative pathway of complement activation.1975
- Cytotoxicity Mediated by Soluble Macrophage Product(s)JNCI Journal of the National Cancer Institute, 1975
- In vitro synthesis of some complement components (C1q, C3 and C4) by lymphoid tissues and circulating leucocytes in man.1975
- Corynebacterium parvum as a Therapeutic Antitumor Agent in Mice. I. Systemic Effects From Intravenous Injection2JNCI Journal of the National Cancer Institute, 1974
- Brief Communication: Induction of Macrophage-Mediated Tumor-Cell Cytotoxicity by Pyran Copolymer2JNCI Journal of the National Cancer Institute, 1974
- In vitro inhibition of tumour cell growth and DNA synthesis by peritoneal and lung macrophages from mice injected withcorynebacterium parvumInternational Journal of Cancer, 1974
- Gross and ultrastructural observations on lesions produced by intradermal injection of human C3a in man.1970
- THE DERIVATION OF TWO DISTINCT ANAPHYLATOXIN ACTIVITIES FROM THE THIRD AND FIFTH COMPONENTS OF HUMAN COMPLEMENTThe Journal of Experimental Medicine, 1968